Skip to main content
Breast Cancer ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
Clinical Topics & News
Military Announces New Breast Cancer Vaccine
Fed Pract
. 2012 February;29(2):27
Read the Full Article
Recommended Reading
Anastrozole and Fulvestrant in Hormone Receptor-Positive Breast Cancer
Breast Cancer ICYMI
Bisphosphonates as Antitumor Agents in Breast Cancer
Breast Cancer ICYMI
Assay for Ductal Carcinoma In Situ
Breast Cancer ICYMI
BOLERO-2: Overcoming Treatment Resistance in Breast Cancer
Breast Cancer ICYMI
The Top 10 Stories on OncologyReport.com in 2011
Breast Cancer ICYMI
CLEOPATRA: Success With Dual HER2 Blockade in Breast Cancer
Breast Cancer ICYMI
Safety of Skin-Sparing Mastectomy Confirmed Short-Term
Breast Cancer ICYMI
Trastuzumab Bests Lapatinib for HER2 Breast Cancer
Breast Cancer ICYMI
Bevacizumab Boosts Treatment Responses in Early Breast Cancer
Breast Cancer ICYMI
Re-Excision Rates After Breast-Conserving Surgery Vary Greatly
Breast Cancer ICYMI
Breast Cancer
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge